UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antecedents and Consequences of Creativity in Product Innovation Teams

The Journal of product innovation management, 2013-01, Vol.30 (1), p.170-185

2013

Volltextzugriff (PDF)

Market Orientation, Creativity, and New Product Performance in High-Technology Firms

Journal of marketing, 2004-04, Vol.68 (2), p.114-132

2004

Volltextzugriff (PDF)

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

Clinical pharmacology and therapeutics, 2013-03, Vol.93 (3), p.252-259

2013

Volltextzugriff (PDF)

Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone

Cancer letters, 2004-04, Vol.206 (2), p.149-157

Workman, Paul

2004

Volltextzugriff (PDF)

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset

Psychological medicine, 2016-11, Vol.46 (15), p.3065-3080

2016

Volltextzugriff (PDF)

Guidelines for the welfare and use of animals in cancer research

British journal of cancer, 2010-05, Vol.102 (11), p.1555-1577

2010

Volltextzugriff (PDF)

One‐year change in cognitive flexibility and fine motor function in middle‐aged male and female marmosets (Callithrix jacchus)

American journal of primatology, 2019-02, Vol.81 (2), p.e22924-n/a

2019

Volltextzugriff (PDF)

Inhibiting the phosphoinositide 3-kinase pathway for cancer treatment

Biochemical Society transactions, 2004-04, Vol.32 (Pt 2), p.393-396

Workman, P

2004

Volltextzugriff (PDF)

A Configurational Perspective on Key Account Management

Journal of marketing, 2002-04, Vol.66 (2), p.38-60

2002

Volltextzugriff (PDF)

Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors

Oncogene, 2009-01, Vol.28 (2), p.157-169

2009

Volltextzugriff (PDF)

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations

British journal of cancer, 2005-05, Vol.92 (9), p.1599-1610

2005

Volltextzugriff (PDF)

Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors

Current medicinal chemistry, 2011-06, Vol.18 (18), p.2686-2714

2011

Volltextzugriff (PDF)

Intraorganizational Determinants of Key Account Management Effectiveness

Journal of the Academy of Marketing Science, 2003-12, Vol.31 (1), p.3-21

2003

Volltextzugriff (PDF)

Robustness of sex-differences in functional connectivity over time in middle-aged marmosets

Scientific reports, 2020-10, Vol.10 (1), p.16647-16647, Article 16647

2020

Volltextzugriff (PDF)

Challenges of PK/PD measurements in modern drug development

European journal of cancer (1990), 2002-11, Vol.38 (16), p.2189-2193

Workman, P.

2002

Volltextzugriff (PDF)

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; -Roscovitine), administered twice daily for 7 days every 21 days

British journal of cancer, 2007-01, Vol.96 (1), p.29-37

2007

Volltextzugriff (PDF)

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins

Oncogene, 2015-01, Vol.34 (1), p.15-26

2015

Volltextzugriff (PDF)

Combinatorial targets for the treatment of ovarian cancers with phosphatidylinositol-3-kinase inhibitors

European journal of cancer (1990), 2016-12, Vol.69, p.S22-S22

2016

Volltextzugriff (PDF)

Modelling the sulfate capacity of simulated radioactive waste borosilicate glasses

Journal of alloys and compounds, 2017-02, Vol.695 (C), p.656-667

2017

Volltextzugriff (PDF)

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

Blood cancer journal (New York), 2017-03, Vol.7 (3), p.e549-e549

2017

Volltextzugriff (PDF)

Fundamental Changes in Marketing Organization: The Movement toward a Customer-Focused Organizational Structure

Journal of the Academy of Marketing Science, 2000-10, Vol.28 (4), p.459-478

2000

Volltextzugriff (PDF)

Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns

Leukemia, 2012-07, Vol.26 (7), p.1462-1470

2012

Volltextzugriff (PDF)

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D

Oncogene, 2020-06, Vol.39 (24), p.4780-4780

2020

Volltextzugriff (PDF)

Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma

Leukemia, 2010-10, Vol.24 (10), p.1804-1807

2010

Volltextzugriff (PDF)

Sex differences in cognitive aging: a 4-year longitudinal study in marmosets

Neurobiology of aging, 2022-01, Vol.109, p.88-99

2022

Volltextzugriff (PDF)

1 – 25 von 1.624

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.420)
Mit Volltextzugriff
(1.310)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Antecedents and Consequences of Creativity in Product Innovation Teams

Market Orientation, Creativity, and New Product Performance in High-Technology Firms

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset

Guidelines for the welfare and use of animals in cancer research

One‐year change in cognitive flexibility and fine motor function in middle‐aged male and female marmosets (Callithrix jacchus)

Inhibiting the phosphoinositide 3-kinase pathway for cancer treatment

A Configurational Perspective on Key Account Management

Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations

Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors

Intraorganizational Determinants of Key Account Management Effectiveness

Robustness of sex-differences in functional connectivity over time in middle-aged marmosets

Challenges of PK/PD measurements in modern drug development

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; -Roscovitine), administered twice daily for 7 days every 21 days

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins

Combinatorial targets for the treatment of ovarian cancers with phosphatidylinositol-3-kinase inhibitors

Modelling the sulfate capacity of simulated radioactive waste borosilicate glasses

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

Fundamental Changes in Marketing Organization: The Movement toward a Customer-Focused Organizational Structure

Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D

Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma

Sex differences in cognitive aging: a 4-year longitudinal study in marmosets

Suchergebnisse filtern